Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
189.4 INR | -2.22% | -6.10% | -8.66% |
May. 09 | Transcript : Nath Bio-Genes Limited, Q4 2024 Earnings Call, May 09, 2024 | |
May. 08 | Nath Bio-Genes Limited Recommends Dividend for Financial Year 2023-24 | CI |
Sales 2022 | 2.78B 33.34M | Sales 2023 | 3.01B 36.09M | Capitalization | 2.68B 32.15M |
---|---|---|---|---|---|
Net income 2022 | -673M -8.06M | Net income 2023 | 350M 4.19M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 888M 10.63M | Net Debt 2023 | 672M 8.05M | EV / Sales 2023 | 1.11 x |
P/E ratio 2022 |
-6.02
x | P/E ratio 2023 |
7.67
x | Employees | 433 |
Yield 2022 |
0.94% | Yield 2023 |
1.42% | Free-Float | 38.47% |
Latest transcript on Nath Bio-Genes (India) Limited
1 day | -2.22% | ||
1 week | -6.10% | ||
Current month | -8.30% | ||
1 month | -1.30% | ||
3 months | -12.09% | ||
6 months | -4.13% | ||
Current year | -8.66% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 99-08-29 | |
Director of Finance/CFO | 63 | - | |
Compliance Officer | 30 | 18-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 99-08-29 | |
Director/Board Member | 60 | 12-10-09 | |
Director/Board Member | 42 | 15-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 189.4 | -2.22% | 4,688 |
24-05-09 | 193.7 | -5.19% | 4,850 |
24-05-08 | 204.3 | +2.84% | 7,617 |
24-05-07 | 198.6 | -0.18% | 863 |
24-05-06 | 199 | -1.34% | 7,370 |
Delayed Quote Bombay S.E., May 10, 2024 at 06:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+14.71% | 3.36B | |
-95.58% | 1.61B | |
-1.81% | 1.58B | |
+0.53% | 1.29B | |
-8.31% | 1.23B | |
-11.54% | 1.21B | |
-.--% | 1.21B | |
0.00% | 1.2B | |
+9.51% | 1.18B |
- Stock Market
- Equities
- NATHBIOGEN Stock
- NATHBIOGEN Stock